Company Valuation: Bio-Rad Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,439 12,460 9,399 9,182 8,212 10,217 - -
Change - -44.47% -24.57% -2.31% -10.57% 24.42% - -
Enterprise Value (EV) 1 22,439 11,868 8,992 8,730 7,874 9,468 9,252 9,111
Change - -47.11% -24.24% -2.91% -9.8% 20.24% -2.29% -1.53%
P/E 5.38x - -14.8x -5.03x 10.9x 46.4x 45.4x 45.7x
PBR - 1.27x 1.05x 1.41x 1.11x - - -
PEG - - - -0x -0x -0.7x 21.01x -64.82x
Capitalization / Revenue 7.68x 4.45x 3.52x 3.58x 3.18x 3.97x 3.88x 3.81x
EV / Revenue 7.68x 4.24x 3.37x 3.4x 3.05x 3.68x 3.51x 3.4x
EV / EBITDA 33.1x 17.8x 16.8x 18.2x 17.4x 23.1x 21.3x 20.4x
EV / EBIT 39.3x 22.7x 23.7x 26.4x 25.3x 32.9x 29.1x 27.7x
EV / FCF 41.9x 127x 24x - - 30.8x 29.3x 27.5x
FCF Yield 2.39% 0.79% 4.17% - - 3.24% 3.41% 3.64%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 140.6 - -21.82 -65.36 27.85 8.33 8.51 8.45
Distribution rate - - - - - - - -
Net sales 1 2,923 2,802 2,671 2,566 2,583 2,573 2,633 2,682
EBITDA 1 677.5 667.9 535.9 479.5 453.2 410.3 435 446.5
EBIT 1 571.2 524 378.9 331.3 311.6 287.5 318.4 328.8
Net income 1 4,246 -3,628 -637.3 -1,844 759.9 225 230 228
Net Debt 1 - -592.5 -407.6 -452.1 -337.7 -749 -965.4 -1,107
Reference price 2 755.57 420.49 322.89 328.51 302.99 386.11 386.11 386.11
Nbr of stocks (in thousands) 29,918 29,824 29,145 27,997 26,975 26,738 - -
Announcement Date 2/10/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
31.08x4.2x16.15x2.37% 187B
19.92x3.63x12.95x3.01% 120B
18.12x0.21x13.19x0.72% 63.15B
29.59x7.29x18.82x1.35% 51.75B
35.6x3.43x11.76x2.12% 50.32B
35.23x6.2x19.45x-.--% 33.17B
47.24x1.35x12.52x0.2% 32.1B
39.65x6.94x24.91x0.27% 23.93B
18.12x2.89x10.23x1.53% 22.99B
Average 30.51x 4.02x 15.55x 1.29% 65.03B
Weighted average by Cap. 28.60x 3.88x 15.15x 1.84%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. BIO Stock
  4. BUWA Stock
  5. Valuation Bio-Rad Laboratories, Inc.